MORC2 mutations cause Charcot-Marie-Tooth neuropathy type 2Z disease [42], and recent research showed that MORC2 is aberrantly highly expressed in many cancers, including breast cancer [25,35], hepatocellular carcinoma cells [18], and gastric cancer cells [43]. This evidence concerns the gene MORC2 and breast cancer.